Detection and quantification of benzodiazepines and Z-drugs in human whole blood, plasma, and serum samples as part of a comprehensive multi-analyte LC-MS/MS approach
- 6 December 2013
- journal article
- research article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 406 (3) , 803-818
Abstract
For the first time, a liquid chromatography-tandem mass spectrometry (LC-MS/MS) multi-analyte approach based on a simple liquid–liquid extraction was developed and validated for fast target screening and quantification of benzodiazepines and Z-drugs in case of driving ability and crime responsibility in the three most important biosamples whole blood, plasma, and serum. Whole blood, plasma, and serum (500 μL each) were extracted twice at pH 7.4 and at pH 10 with ether/ethyl acetate (1:1). Separation, detection, and quantification were performed using LC-MS/MS with electrospray ionization in positive mode. The method was validated with respect to selectivity, ion suppression/enhancement of co-eluting analytes, matrix effects, recovery, process efficiency, accuracy and precision, stabilities, and limits of detection and quantification. For accuracy and precision, full calibration was performed with ranges from subtherapeutic to toxic concentrations. The presented LC-MS/MS approach as part of a universal multi-analyte concept for over 100 drugs was applicable for selective detection as well as accurate and precise quantification in whole blood, plasma, and serum. The approach was selective, sensitive, accurate, and precise for 16 of the 19 tested drugs in whole blood, 18 in plasma, and 17 in serum. Only semiquantitative results could be obtained for zopiclone because of its instability in all tested biosamples.Keywords
This publication has 17 references indexed in Scilit:
- Detection and Validated Quantification of the Phosphodiesterase Type 5 Inhibitors Sildenafil, Vardenafil, Tadalafil, and 2 of Their Metabolites in Human Blood Plasma by LC-MS/MS─Application to Forensic and Therapeutic Drug Monitoring CasesTherapeutic Drug Monitoring, 2012
- Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobioticsCritical Care, 2012
- Analyses of benzodiazepines and their metabolites in various biological matrices by LC‐MS(/MS)Biomedical Chromatography, 2011
- Development of an LC–MS/MS method for the quantitation of 55 compounds prescribed in combined cardiovascular therapyJournal of Chromatography B, 2011
- Identification and quantification of 30 antipsychotics in blood using LC‐MS/MSJournal of Mass Spectrometry, 2010
- Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002–2007Forensic Science International, 2009
- Validation of new methodsForensic Science International, 2007
- Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicologyClinical Biochemistry, 2005
- Screening, library‐assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionizationJournal of Mass Spectrometry, 2004
- Driving and Benzodiazepine UseCNS Drugs, 1998